| |
|
|
|
|
|
|
|||
|
RA Rudders, A Levin, D Jespersen, J Zacks, R Delellis, A Ranger and T Krontiris
Department of Medicine, Tufts University School of Medicine, Boston, MA.
We have examined an unselected series of 72 lymphomas of diverse
histologies with a panel of mouse monoclonal antibodies specific for human
B-lymphoma-derived Ig idiotypes (anti-ids) to determine the nature and
extent of id/anti-id crossreactivity. The anti-id antibodies were prepared
from Ig isolated from seven follicular center cell lymphomas by
heterohybridoma technique. Thirty-six of 75 individual anti-ids obtained in
this manner were further selected based on their reactivity with highly
restricted or private idiotypic determinants. Twelve of the 72 (17%)
lymphoma biopsies reacted with one or more of the 36 anti-ids that detect
private determinants. A pool consisting of five individual antibodies would
have detected 11 of the 12 crossreacting tumors. Staining of tumor cell
populations was homogeneous in the positive cases, suggesting uniform
idiotype expression. If there was a segregated staining pattern, it was
generally related to the presence of CD3+ T cells in the section. These
follicular center cell-derived anti-ids cross-reacted with follicular
center cell tumors of all histologic grades with frequencies ranging from
13% to 50%. The structural basis for the crossreactivity of our
lymphoma-derived private anti-ids is as yet not known. However, the
reactivity of certain anti-ids with both kappa- and lambda-expressing
tumors suggests a biased use of V gene segments in these crossreactive
clones that is probably related to the VH gene. These data suggest the
possibility that lymphoma may develop in a highly restricted pool of normal
differentiated B cells or in B-cell subsets that express a limited
repertoire of unmutated VH gene segments.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1992 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||